Romosozumab: A Novel Injectable Sclerostin Inhibitor With Anabolic and Antiresorptive Effects for Osteoporosis [0.03%]
罗莫索珠单抗：一种用于骨质疏松症具有成骨和抗吸收作用的新型注射用抗硬蛋白 tố抑制剂
Kimberly Lovin Nealy,Kira B Harris
Kimberly Lovin Nealy
Objective: To review the clinical pharmacology, efficacy, and safety of romosozumab, a humanized monoclonal antibody with a novel mechanism of action for monthly injection, and its place in the management of osteoporosis....
Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction [0.03%]
静脉双膦酸盐治疗现有肾功能不全的高钙血症患者的安全部分
Shannon Palmer,Frank Tillman rd,Preetika Sharma et al.
Shannon Palmer et al.
Background: Although intravenous (IV) bisphosphonates are first-line medications for the management of hypercalcemia, studies examining their use in patients with preexisting renal dysfunction are limited. ...
A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis [0.03%]
单中心回顾性评价口服Xa因子抑制剂在脑静脉血栓形成患者中的应用
Marissa Powell,Kathryn Tremolet de Villers,Kerry Schwarz et al.
Marissa Powell et al.
Background: Clinical practice guidelines recommend that cerebral venous thrombosis (CVT) be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight heparin (LMWH) for 3 to 12 months. However, o...
Brian L Erstad
Brian L Erstad
Physicians and nurses have received many accolades in commercial and scientific media for their heroic efforts in caring for patients with COVID-19. These accolades are appropriate and deserved. However, there are a number of clinical pharm...
Phenobarbital Monotherapy for the Management of Alcohol Withdrawal Syndrome in Surgical-Trauma Patients [0.03%]
外科创伤患者酒精戒断综合征的苯巴比妥单药治疗
Mahmoud A Ammar,Abdalla A Ammar,Jordan Rosen et al.
Mahmoud A Ammar et al.
Background: Benzodiazepine is first-line therapy for alcohol withdrawal syndrome (AWS), and phenobarbital is an alternative therapy. However, its use has not been well validated in the surgical-trauma patient population. ...
Impact of Telehealth Interventions on Medication Adherence for Patients With Type 2 Diabetes, Hypertension, and/or Dyslipidemia: A Systematic Review [0.03%]
远程医疗干预对2型糖尿病、高血压和/或血脂异常患者的药物依从性的影响：系统评价
Jennifer M Bingham,Melissa Black,Elizabeth J Anderson et al.
Jennifer M Bingham et al.
Objective: To describe telehealth interventions and determine their effect on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia. ...
Prevention and Management of Genital Mycotic Infections in the Setting of Sodium-Glucose Cotransporter 2 Inhibitors [0.03%]
钠-葡萄糖共转运子2抑制剂使用背景下的生殖器真菌感染的预防和治疗
Kristin Engelhardt,McKenzie Ferguson,Jennifer L Rosselli
Kristin Engelhardt
Objective: To review the incidence, risk factors, prevention, and management of genital mycotic infections (GMIs) associated with sodium-glucose cotransporter 2 (SGLT2) inhibitors. ...
Review of Newer Antidiabetic Agents for Diabetes Management in Kidney Transplant Recipients [0.03%]
肾移植受者糖尿病管理中新抗 diabetic agents 的回顾
Sonya Anderson,Laura Cotiguala,Sarah Tischer et al.
Sonya Anderson et al.
Objective: This systematic review describes the efficacy, safety, and drug interactions of dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and sodium-glucose transport pro...
Marnie T Janson,Jacquelyn L Bainbridge
Marnie T Janson
Epilepsy is one of the most common neurological diseases, and uncontrolled seizures remain a significant problem for one-third of patients with epilepsy on drug therapy. Ongoing seizures affect the morbidity and mortality of patients with e...
Pharmacists' Patient Care Process: State "Scope of Practice" Priorities for Action [0.03%]
药师的患者护理过程：州“执业范围”的行动重点
Alex J Adams,Krystalyn K Weaver
Alex J Adams
To fully engage in the Pharmacists' Patient Care Process, pharmacists must be able to (1) participate in a Collaborative Practice Agreement, (2) order and interpret laboratory tests, (3) prescribe certain medications, (4) adapt medications,...